Xact Kapitalforvaltning’s Ironwood Pharmaceuticals IRWD Stock Holding History

Xact Kapitalforvaltning’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$273K	Hold	27,055	–	–	0.01%	1063
2019 Q4	$360K	Hold	27,055	–	–	0.01%	1158
2019 Q3	$232K	Hold	27,055	–	–	﹤0.01%	1329
2019 Q2	$296K	Sell	27,055 -5,249	-16%	-$58.8K	0.01%	1238
2019 Q1	$366K	Hold	32,304	–	–	0.01%	1102
2018 Q4	$280K	Buy	32,304 +3,105	+11%	+$35.6K	0.01%	1272
2018 Q3	$451K	Buy	29,199 +2,746	+10%	+$43.4K	0.01%	1045
2018 Q2	$424K	Sell	26,453 -597	-2%	-$8.84K	0.01%	1070
2018 Q1	$350K	Buy	27,050 +9,552	+55%	+$119K	0.01%	1105
2017 Q4	$220K	Buy	+17,498	New	+$229K	0.01%	1184

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Xact Kapitalforvaltning's IRWD Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2020 at 27,055 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #1063.

Xact Kapitalforvaltning first reported a position in IRWD in Q4 2017 and has held it in 10 quarters since. The position peaked at $451K in Q3 2018. 193 funds tracked by Wall St. Rank hold IRWD as of Q1 2020.

Xact Kapitalforvaltning held 27,055 shares of Ironwood Pharmaceuticals worth $273K as of Q1 2020.
Xact Kapitalforvaltning left its Ironwood Pharmaceuticals share count unchanged in Q1 2020.
Ironwood Pharmaceuticals made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1063 holding.
Xact Kapitalforvaltning first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Ironwood Pharmaceuticals position peaked at $451K in Q3 2018.
193 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.